Compare FSM & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FSM | ITGR |
|---|---|---|
| Founded | 1990 | 1970 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.7B |
| IPO Year | N/A | 2000 |
| Metric | FSM | ITGR |
|---|---|---|
| Price | $11.68 | $86.13 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $11.00 | ★ $86.67 |
| AVG Volume (30 Days) | ★ 7.0M | 503.1K |
| Earning Date | 03-04-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 809.52 | N/A |
| EPS | 0.74 | ★ 2.42 |
| Revenue | $1,256,829,000.00 | ★ $1,831,074,000.00 |
| Revenue This Year | $0.28 | $9.58 |
| Revenue Next Year | $11.27 | N/A |
| P/E Ratio | ★ $15.38 | $35.44 |
| Revenue Growth | ★ 68.17 | 9.54 |
| 52 Week Low | $4.13 | $62.00 |
| 52 Week High | $11.77 | $146.36 |
| Indicator | FSM | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 73.94 | 67.91 |
| Support Level | $9.93 | $84.41 |
| Resistance Level | $10.82 | $87.69 |
| Average True Range (ATR) | 0.47 | 2.39 |
| MACD | 0.11 | 0.23 |
| Stochastic Oscillator | 95.97 | 88.98 |
Fortuna Mining Corp is a Canadian-based precious metals mining company with mines in the Latin America and West Africa regions producing gold and silver. It operate mines in Argentina, Burkina Faso, Cote d'Ivoire, Mexico, and Peru. The company's segment consists of Mansfield, Sanu, Sango, Cuzcatlan, Bateas, Corporate. The company generates the majority of its revenue from Sango segment which operates the Seguela gold mine. Geographically, the company generates the majority of its revenue from Cote d'Ivoire location.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.